Waiting for new medicines in Canada, Europe, and the United States: Study finds Americans get better and faster access to innovative drugs
April 11, 2024 10:30 ET
|
Canadian Health Policy Institute Inc.
Americans get better and faster access to innovative medicines compared to Europeans and Canadians.
Access to new medicines in Canada, Europe, and the United States: Study finds less availability and longer waits for Canadian patients
April 11, 2024 10:00 ET
|
Canadian Health Policy Institute Inc.
A recent study published by the Canadian Health Policy Institute examined the availability and wait times for access to new drugs.
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy
February 23, 2024 07:05 ET
|
Travere Therapeutics, Inc.
Committee for Medicinal Products for Human Use (CHMP) recommends approval of the conditional marketing authorization (CMA) for sparsentan for the treatment of IgA nephropathy (IgAN) in Europe ...
Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant
February 02, 2024 16:05 ET
|
NurExone Biologic Inc
Nurexone Biologic Initiates European Orphan Drug Designation Process Following U.S. Grant for its groundbreaking ExoPTEN product
Ecological Momentary Assessment Market To Reach USD 59.9 Million By 2032, Says DataHorizzon Research
January 18, 2024 07:10 ET
|
DataHorizzon Research
Fort Collins, Colorado, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The Ecological Momentary Assessment Market was valued at USD 12.1 Million in 2022 and is anticipated to grow CAGR at 17.4% to reach USD 59.9...
OpsMx Named to First Annual EMA Allstars 2024 List
January 10, 2024 16:21 ET
|
OpsMx
SUNNYVALE, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- OpsMx, the leader in secure software delivery, today announced it is featured in the inaugural 2024 EMA Allstars list in the “DevSecOps Platform...
Harvard Apparatus Regenerative Technology Reports Third Quarter 2023 Financial Results
November 13, 2023 09:00 ET
|
Harvard Apparatus Regenerative Technology, Inc.
Holliston, MA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage...
Stonebranch Named a Value Leader in the 2023 EMA Radar™ Report for Workload Automation and Orchestration
October 02, 2023 09:00 ET
|
Stonebranch
ALPHARETTA, Ga., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Stonebranch, a leading provider of service orchestration and automation solutions, announced today that it has been named a Value Leader in the...
AB Science fait une mise au point sur le calendrier de l’EMA concernant l'examen de la demande d'autorisation de mise sur le marché du masitinib dans la SLA
September 18, 2023 12:05 ET
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE FAIT LE POINT SUR LE CALENDRIER DE L'AGENCE EUROPÉENNE DES MÉDICAMENTS CONCERNANT L'EXAMEN DE LA DEMANDE D'AUTORISATION DE MISE SUR LE MARCHÉ DU MASITINIB DANS LA...
AB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS
September 18, 2023 12:05 ET
|
AB Science
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE EUROPEAN MEDICINES AGENCY'S TIMETABLE FOR EXAMINATION OF THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...